SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001593034-20-000017
Filing Date
2020-02-26
Accepted
2020-02-26 06:04:48
Documents
16
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12312019er8-kshell.htm   iXBRL 8-K 53377
2 EXHIBIT 99.1 ex991-12312019xearning.htm EX-99.1 1247258
8 endologoa27.jpg GRAPHIC 28449
  Complete submission text file 0001593034-20-000017.txt   1552908

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20200226.xsd EX-101.SCH 4629
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT endp-20200226_cal.xml EX-101.CAL 669
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20200226_def.xml EX-101.DEF 3685
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20200226_lab.xml EX-101.LAB 30176
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20200226_pre.xml EX-101.PRE 15634
14 EXTRACTED XBRL INSTANCE DOCUMENT a12312019er8-kshell_htm.xml XML 4465
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 20653220
SIC: 2834 Pharmaceutical Preparations